Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates
- Status
- TERMINATED
- Phase
- NA
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
- Status
- COMPLETED
- Phase
- PHASE3
PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Amifostine For SCCHN
- Status
- COMPLETED
- Phase
- PHASE2
Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)
- Status
- COMPLETED
- Phase
- PHASE2
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE3
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania
- Status
- COMPLETED
- Phase
- PHASE3
AZD5438 in Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
CP-675,206 In Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2